JY
LEXX icon

Jeff Yass’s Lexaria Bioscience LEXX Stock Holding History

Jeff Yass’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.55K Buy
+1,018
New +$11K ﹤0.01% 13154
2023
Q3 		– Sell
-1,028
Closed -$11.2K – 12531
2023
Q2 		$11.2K Sell
1,028
-3,469
-77% -$67.4K ﹤0.01% 11745
2023
Q1 		$183K Buy
4,497
+88
+2% +$3.76K ﹤0.01% 10701
2022
Q4 		$162K Buy
4,409
+1,734
+65% +$62.3K ﹤0.01% 10406
2022
Q3 		$98K Buy
+2,675
New +$114K ﹤0.01% 11725

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jeff Yass's LEXX Position: Q2 2026 in Review

Jeff Yass opened a new position in Lexaria Bioscience (LEXX) in Q2 2026: 1,018 shares worth $8.55K. The stake represents ﹤0.01% of the portfolio and ranks #13154 among its holdings. This is a return to the name: Jeff Yass previously reported a position in LEXX as recently as Q2 2023.

Jeff Yass first reported a position in LEXX in Q3 2022 and has held it in 5 quarters since. The position peaked at $183K in Q1 2023. 29 funds tracked by Wall St. Rank hold LEXX as of Q2 2026.

  • Jeff Yass held 1,018 shares of Lexaria Bioscience worth $8.55K as of Q2 2026.
  • Lexaria Bioscience was a new Jeff Yass position in Q2 2026.
  • Lexaria Bioscience made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13154 holding.
  • Jeff Yass first reported a position in Lexaria Bioscience in Q3 2022 and has held it in 5 quarters since.
  • Jeff Yass's Lexaria Bioscience position peaked at $183K in Q1 2023.
  • 29 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.